Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2020 | Story UFS entral academic advising team | Photo Pixabay

It wasn’t easy, but we all got to this point because we stayed calm and made the effort to learn on even when it was difficult. 

The University of the Free State (UFS) has remained committed to supporting you in every way possible, and as you prepare for the final assessments, remember to access the support tools you will need in order to successfully complete the 2020 academic year: https://www.ufs.ac.za/toolsforsuccess 

Main exams are running from 30 November to 19 December 2020


All of the best, and break a pen in your upcoming final assessments. For those of you who will be graduating, we cannot wait to see you in that graduation attire; and those who still have some way to go, we cannot wait to serve you again in 2021 as we continue the pursuit of academic success!

Below are five main study tips that you can use for final assessment success:


1. Set a realistic study schedule
You might think that studying for eight hours straight for four days before the exam, will help you get through the work in time. See final edition of the #UFSLearnOn for more information.

2. Structure and organise your work

If your notes are organised, it is also easier for your brain to recall information, even when you become nervous during exams. 

3. Practise with an old exam/semester test paper
Practice makes perfect, and although the final assessments might look different in how they are administered, it will still help to practise using old tests and exams. 

4. Adapt your strategies to the content
What works for one module or even one learning outcome, might not be effective for another. You need to continually adapt your note-taking and study approaches. See #UFSLearnOn final edition for different study methods.

5. Healthy body, healthy mind
Your brain needs optimal care to perform at its best, and getting physically active (even if it is by jumping in one spot if space is limited) forces your body to release neurotransmitters responsible for positive emotions, which assist in retaining information in your memory … 
Download the final edition of #UFSLearnOn that points you towards the resources you’ll need to ace your final assessments and end 2020 off on a high note! 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept